Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis-Reference-Cited by-同舟云学术

Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis

Published:2014-08-27 Issue:2 Volume:35 Page:660-672
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Zachou Kalliopi¹,Gampeta Stella¹,Gatselis Nikolaos K.¹,Oikonomou Katerina¹,Goulis John²,Manoussakis Menelaos N.³,Renaudineau Yves⁴,Bogdanos Dimitrios P.⁵⁶,Dalekos George N.¹

Affiliation:

1. Department of Medicine and Research Laboratory of Internal Medicine; School of Medicine; University of Thessaly; Larissa Greece

2. 4th Department of Internal Medicine; School of Medicine; Aristotelian University of Thessaloniki; Thessaloniki Greece

3. Department of Pathophysiology; School of Medicine; National University of Athens; Athens Greece

4. Research Unit EA2216 Immunology and Pathology; Hôpital Morvan et Cavale blanche; Université Européenne de Bretagne; France and Université de Brest; IFR 148 ScInBioS; CHU Brest; Brest France

5. Division of Rheumatology; School of Medicine; University of Thessaly; Larissa Greece

6. Institute of Liver Studies; King's College London School of Medicine; London UK

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12658/fullpdf

Reference45 articles.

1. Review article: autoimmune hepatitis - current management and challenges;Zachou;Aliment Pharmacol Ther,2013

2. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview;Dalekos;Eur J Intern Med,2002

3. Simplified criteria for the diagnosis of autoimmune hepatitis;Hennes;Hepatology,2008